The Apoptotic Effect of the Methanol Extract of <i>Polygonum cuspidatum</i> through Up-Regulation Death Receptor 5 and CHOP in HSC-2 Human Oral Cancer Cells — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Apoptotic Effect of the Methanol Extract of <i>Polygonum cuspidatum</i> through Up-Regulation Death Receptor 5 and CHOP in HSC-2 Human Oral Cancer Cells
,
,
,
,
,
Department of Oral Pathology, School of Dentistry, Institute of Oral Bioscience, Chonbuk National University, Jeonju, South Korea
1
2
3
4
5
6 Department of Oral Pathology, School of Dentistry, Institute of Oral Bioscience, Chonbuk National University, Jeonju, South Korea
Polygonum cuspidatum is used as a traditional medicinal herb for the therapy of various diseases including several types of cancers. In the present study, we focused on addressing the anti-cancer activity and molecular mechanism of methanol extract of Polygonum cuspidatum (MEPC) in HSC-2 human oral cancer cells. The effect of MEPC on oral cancer cells was estimated by 3-(4,5-dimethylthiazol-20yl)-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) assay, 4’-6-diamidino-2-phenylindole (DAPI) staining and Western blot analysis. MEPC inhibited the cell viability and induced apoptosis through the induction of death receptor (DR) 5. MEPC also increased the expression of C/EBP homologous protein/growth arrest and the DNA damage-inducible gene 153 (CHOP), a transcription factor induced by ER stress. Thus, we concluded that the induction of CHOP leading to DR5 up-regulation is required for the anti-cancer activity of MEPC in HSC-2 cells and MEPC may be a promising drug candidate for oral cancer.
Keywords<i>Polygonum cuspidatum</i>Endoplasmic Reticulum StressC/EBP Homologous Protein/Growth Arrest and the DNA Damage-Inducible Gene 153 (CHOP)Death Receptor 5 (DR5)ApoptosisHuman Oral Cancer Cell
G. J. Macfarlane, P. Boyle, T. V. Evstifeeva, C. Robertson and C. Scully, “Rising Trends of Oral Cancer Mortality among Males Worldwide: The Return of an Old Public Health Problem,” Cancer Causes and Control, Vol. 5, No. 3, 1994, pp. 259-265. doi:10.1007/BF01830246
A. Jemal, R. Siegel, J. Xu and E. Ward, “Cancer Statistics, 2010,” CA: A Cancer Journal for Clinical, Vol. 60, No. 5, 2010, pp. 277-300. doi:10.3322/caac.20073
A. G. Zygogianni, G. Kyrgias, P. Karakitsos, A. Psyrri, J. Kouvaris, N. Kelekis and V. Kouloulias, “Oral Squamous Cell Cancer: Early Detection and the Role of Alcohol and Smoking,” Head & Neck Oncology, Vol. 3, 2011, p. 2. doi:10.1186/1758-3284-3-2
A. Zygogianni, G. Kyrgias, K. Mystakidou, C. Antypas, J. Kouvaris, C. Papadimitriou, V. Armonis, H. Alkati and V. Kouloulias, “Potential Role of the Alcohol and Smoking in the Squamous Cell Carcinoma of the Head and Neck: Review of the Current Literature and New Perspectives,” Asian Pacific Journal of Cancer Prevention, Vol. 12, No. 2, 2011, pp. 339-344.
O. I. Mansour, C. H. Snyderman and F. D'Amico, “Association between Tobacco Use and Metastatic Neck Disease,” Laryngoscope, Vol. 113, No. 1, 2003, pp. 161-166. doi:10.1097/00005537-200301000-00030
E. Szegezdi, S. E. Logue, A. M. Gorman and A. Samali, “Mediators of Endoplasmic Reticulum Stress-Induced Apoptosis,” EMBO Reports, Vol. 7, No. 9, 2006, pp. 880-885. doi:10.1038/sj.embor.7400779
C. Xu, B. Bailly-Maitre and J. C. Reed, “Endoplasmic Reticulum Stress: Cell Life and Death Decisions,” The Journal of Clinical Investigation, Vol. 115, No. 10, 2005, pp. 2656-2664. doi:10.1172/JCI26373
E. Araki, S. Oyadomari and M. Mori, “Impact of Endoplasmic Reticulum Stress Pathway on Pancreatic Beta-Cells and Diabetes Mellitus,” Experimental Biology and Medicine, Vol. 228, No. 10, 2003, pp. 1213-1217.
M. J. Gething, “Role and Regulation of the ER Chaperone BiP,” Seminars in Cell & Developmental Biology, Vol. 10, No. 10, 1999, pp. 465-472. doi:10.1006/scdb.1999.0318
R. J. Kaufman, “Stress Signaling from the Lumen of the Endoplasmic Reticulum: Coordination of Gene Transcriptional and Translational Controls,” Genes Development, Vol. 13, No. 10, 1999, pp. 1211-1233. doi:10.1101/gad.13.10.1211
S. Moriya, K. Miyazawa, T. Kawaguchi, X. F. Che and A. Tomoda, “Involvement of Endoplasmic Reticulum Stress-Mediated CHOP (GADD153) Induction in the Cytotoxicity of 2-Aminophenoxazine-3-one in Cancer Cells,” International Journal of Oncology, Vol. 39, No. 4, 2011, pp. 981-988.
M. Abdelrahim, K. Newman, K. Vanderlaag, I. Samudio and S. Safe, “3,3'-Diindolylmethane (DIM) and Its Derivatives Induce Apoptosis in Pancreatic Cancer Cells through Endoplasmic Reticulum Stress-Dependent Upregulation of DR5,” Carcinogenesis, Vol. 27, No. 4, 2006, pp. 717-728. doi:10.1093/carcin/bgi270
W. Zou, P. Yue, F. R. Khuri and S. Y. Sun, “Coupling of Endoplasmic Reticulum Stress to CDDO-Me-Induced Up-Regulation of Death Receptor 5 via a CHOP-Dependent Mechanism Involving JNK Activation,” Cancer Research, Vol. 68, No. 18, 2008, pp. 7484-7492. doi:10.1158/0008-5472.CAN-08-1318
P. Lei, M. Abdelrahim, S. D. Cho, X. Liu and S. Safe, “Structure-Dependent Activation of Endoplasmic Reticulum Stress-Mediated Apoptosis in Pancreatic Cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes,” Molecular Cancer Therapeutics, Vol. 7, No. 10, 2008, pp. 3363-3372. doi:10.1158/1535-7163.MCT-08-0439
S. Chen, X. Liu, P. Yue, A. H. Schonthal, F. R. Khuri and S. Y. Sun, “CCAAT/Enhancer Binding Protein Homologous Protein-Dependent Death Receptor 5 Induction and Ubiquitin/Proteasome-Mediated Cellular FLICE-Inhibitory Protein Down-Regulation Contribute to Enhancement of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Dimethyl-Celecoxib in Human Non Small-Cell Lung Cancer Cells,” Molecular Pharmacology, Vol. 72, No. 5, 2007, pp. 1269-1279. doi:10.1124/mol.107.037465
H. Yamaguchi and H. G. Wang, “CHOP Is Involved in Endoplasmic Reticulum Stress-Induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells,” Journal of Biological Chemistry, Vol. 279, No. 44, 2004, pp. 45495-45502. doi:10.1074/jbc.M406933200
T. Yoshida, T. Shiraishi, S. Nakata, M. Horinaka, M. Wakada, Y. Mizutani, T. Miki and T. Sakai, “Proteasome Inhibitor MG132 Induces Death Receptor 5 through CCAAT/ Enhancer-Binding Protein Homologous Protein,” Cancer Research, Vol. 65, No.13, 2005, pp. 5662-5667. doi:10.1158/0008-5472.CAN-05-0693
S. Y. Lee, M. S. Lee, R. P. Cherla and V. L. Tesh, “Shiga Toxin 1 Induces Apoptosis through the Endoplasmic Reticulum Stress Response in Human Monocytic Cells,” Cellular Microbiology, Vol. 10, No. 3, 2008, pp. 770-780. doi:10.1111/j.1462-5822.2007.01083.x
J. S. Chang, H. W. Liu, K. C. Wang, M. C. Chen, L. C. Chiang, Y. C. Hua and C. C. Lin, “Ethanol Extract of Polygonum cuspidatum Inhibits Hepatitis B Virus in a Stable HBV-Producing Cell Line,” Antiviral Research, Vol. 66, No. 1, 2005, pp. 29-34. doi:10.1016/j.antiviral.2004.12.006
J. Choi, C. C. Conrad, C. A. Malakowsky, J. M. Talent, C. S. Yuan and R. W. Gracy, “Flavones from Scutellaria baicalensis Georgi Attenuate Apoptosis and Protein Oxidation in Neuronal Cell Lines,” Biochimica et Biophysica Acta, Vol. 1571, No. 3, 2002, pp. 201-210. doi:10.1016/S0304-4165(02)00217-9
L. Feng, L. F. Zhang, T. Yan, J. Jin and W. Y. Tao, “Studies on Active Substance of Anticancer Effect in Polygonum cuspidatum,” Zhong Yao Cai, Vol. 29, No. 7, 2006, pp. 689-691.
H. Ghanim, C. L. Sia, S. Abuaysheh, K. Korzeniewski, P. Patnaik, A. Marumganti, A. Chaudhuri and P. Dandona, “An Antiinflammatory and Reactive Oxygen Species Suppressive Effects of an Extract of Polygonum cuspidatum Containing Resveratrol,” Journal of Clinical Endocrinology & Metabolism, Vol. 95, No. 9, 2010, pp. E1-E8. doi:10.1210/jc.2010-0482
Y. Kimura and H. Okuda, “Resveratrol Isolated from Polygonum cuspidatum Root Prevents Tumor Growth and Metastasis to Lung and Tumor-Induced Neovascularization in Lewis Lung Carcinoma-Bearing Mice,” Journal of Nutrition, Vol. 131, No. 6, 2001, pp. 1844-1849.
J. Dong, H. Wang, L. Wan, Y. Hashi and S. Chen, “Identification and Determination of Major Constituents in Polygonum cuspidatum Sieb. et Zucc. by High Performance Liquid Chromatography/Electrospray Ionization-Ion Trap-Time-of-Flight Mass Spectrometry,” Se Pu, Vol. 27, No. 4, 2009, pp. 425-430.
L. Xue, “Progress in the Pharmacological Study of Chinese Herbal Drug: Polygonum cuspidatum,” Zhongguo Zhong Yao Za Zhi, Vol. 25, No. 11, 2000, pp. 651-653.
Y. L. Leu, T. L. Hwang, J. W. Hu and J. Y. Fang, “Anthraquinones from Polygonum cuspidatum as Tyrosinase Inhibitors for Dermal Use,” Phytotherapy Research, Vol. 22, No. 4, 2008, pp. 552-556. doi:10.1210/jc.2010-0482
S. Banerjee, C. Bueso-Ramos and B. B. Aggarwal, “Suppression of 7,12-Dimethylbenz(a) Anthracene-Induced Mammary Carcinogenesis in Rats by Resveratrol: Role of Nuclear Factor-kB, Cyclooxygenase 2 and Matrix Metalloprotease 9,” Cancer Research, Vol. 62, No. 17, 2002, pp. 4945-4954.
A. Kumar, S. Dhawan and B. B. Aggarwal, “Emodin (3-Methyl-1,6,8-trihydroxyanthraquinone) Inhibits TNF-Induced NF-kB Activation, IkB Degradation and Expression of Cell Surface Adhesion Proteins in Human Vascular Endothelial Cells,” Oncogene, Vol. 17, No. 7, 1998, pp. 913-918. doi:10.1038/sj.onc.1201998
S. H. Lee, S. Y. Ryu, H. B. Kim, M. Y. Kim and Y. J. Chun, “Induction of Apoptosis by 3,4'-Dimethoxy-5-hydroxystilbene in Human Promyeloid Leukemic HL-60 Cells,” Planta Medicine, Vol. 68, No. 2, 2002, pp. 123-127. doi:10.1055/s-2002-20242
Y. W. Lin, F. J. Yang, C. L. Chen, W. T. Lee and R. S. Chen, “Free Radical Scavenging Activity and Antiproliferative Potential of Polygonum cuspidatum Root Extracts,” Journal of Natural Medicine, Vol. 64, No. 2, 2010, pp. 146-152. doi:10.1007/s11418-009-0387-8
J. A. Shin, J. H. Shim, J. G. Jeon, K. H. Choi, E. S. Choi, N. P. Cho and S. D. Cho, “Apoptotic Effect of Polygonum cuspidatum in Oral Cancer Cells through the Regulation of Specificity Protein 1,” Oral Diseases, Vol. 17, No. 2, 2011, pp. 162-170. doi:10.1111/j.1601-0825.2010.01710.x
I. S. Lee, A. Nishikawa, F. Furukawa, K. Kasahara and S. U. Kim, “Effects of Selaginella tamariscina on in Vitro Tumor Cell Growth, P53 Expression, G 1 Arrest and in Vivo Gastric Cell Proliferation,” Cancer Letters, Vol. 144, No. 1, 1999, pp. 93-99. doi:10.1016/S0304-3835(99)00202-5
E. Lee, K. K. Park, J. M. Lee, K. S. Chun, J. Y. Kang, S. S. Lee and Y. J. Surh, “Suppression of Mouse Skin Tumor Promotion and Induction of Apoptosis in HL-60 Cells by Alpinia oxyphylla Miquel (Zingiberaceae),” Carcinogenesis, Vol. 19, No.8, 1998, pp. 1377-1381. doi:10.1093/carcin/19.8.1377
W. Ren and D. G. Tang, “Extract of Solanum muricatum (Pepino/CSG) Inhibits Tumor Growth by inducing Apoptosis,” Anticancer Research, Vol. 19, No. 1, 1999, pp. 403-408.
A. K. Taraphdar, M. Roy and R. K. Bhattacharya, “Natural Products as Inducers of Apoptosis: Implication for Cancer Therapy and Prevention,” Current Science, Vol. 80, No. 11, 2001, pp. 1387-1396.
S. M. Raja, S. Chen, P. Yue, T. M. Acker, B. Lefkove, J. L. Arbiser, F. R. Khuri and S. Y. Sun, “The Natural Product Honokiol Preferentially Inhibits Cellular FLICE-Inhibitory Protein and Augments Death Receptor-Induced Apoptosis,” Molecular Cancer Therapeutics, Vol. 7, No. 7, 2008, pp. 2212-2223. doi:10.1158/1535-7163.MCT-07-2409
H. Hasegawa, Y. Yamada, K. Komiyama, M. Hayashi, M. Ishibashi, T. Yoshida, T. Sakai, T. Koyano, T. S. Kam, K. Murata, K. Sugahara, K. Tsuruda, N. Akamatsu, K. Tsukasaki, M. Masuda, N. Takasu and S. Kamihira, “Dihy-droflavonol BB-1, an Extract of Natural Plant Blumea balsamifera, Abrogates TRAIL Resistance in Leukemia Cells,” Blood, Vol. 107, No. 2, 2006, pp. 679-688. doi:10.1182/blood-2005-05-1982
M. Endo, S. Oyadomari, M. Suga, M. Mori and T. Gotoh, “The ER Stress Pathway Involving CHOP Is Activated in the Lungs of LPS-Treated Mice,” Journal of Biochemistry, Vol. 138, No. 4, 2005, pp. 501-507. doi:10.1093/jb/mvi143
J. A. Shin, J. H. Shim, E. S. Choi, D. H. Leem, K. H. Kwon, S. O. Lee, S. Safe, N. P. Cho and S. D. Cho, “Chemopreventive Effects of Synthetic C-Substituted Diindolylmethanes Originating from Cruciferous Vegetables in Human Oral Cancer Cells,” European Journal of Cancer Prevention, Vol. 20, No. 5, 2011, pp. 417-425. doi:10.1097/CEJ.0b013e32834473c3